TGFB1 and pulmonary fibrosis: Diammonium glycyrrhizate played anti-pulmonary fibrosis effects by reducing the secretion of TGFβ1 and connective tissue growth factor in lung tissue (Li, 2018b), and could reduce chronic lung injury through anti-inflammatory effects (Bu et al., 2010).